HOME › DRUGS › AZITHROMYCIN
ACTIVE SUBSTANCE / INN

AZITHROMYCIN

Brand name(s): AZASITE, ZITHROMAX, ZMAX, AZITHROMYCIN
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA207566
ANDA202308
ACTIVE SUBSTANCE
Azithromycin
REGULATORS
FDA
SPONSORS / MAH
TEVA, PF PRISM CV, SANDOZ INC
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
AZITHROMYCINANDA207566CSPC OUYIPrescription
ZITHROMAXNDA050710PFIZERPrescription
AZITHROMYCINANDA065153TEVADiscontinued
ZITHROMAXNDA050670PFIZERDiscontinued
AZITHROMYCINANDA202308SANDOZ INCNone (Tentative Approval)
AZASITENDA050810THEA PHARMAPrescription
ZMAXNDA050797PF PRISM CVDiscontinued

FULL INTELLIGENCE ON AZITHROMYCIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →